These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8592166)

  • 1. Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells.
    Sadot E; Gurwitz D; Barg J; Behar L; Ginzburg I; Fisher A
    J Neurochem; 1996 Feb; 66(2):877-80. PubMed ID: 8592166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.
    Fisher A; Heldman E; Gurwitz D; Haring R; Karton Y; Meshulam H; Pittel Z; Marciano D; Brandeis R; Sadot E; Barg Y; Pinkas-Kramarski R; Vogel Z; Ginzburg I; Treves TA; Verchovsky R; Klimowsky S; Korczyn AD
    Ann N Y Acad Sci; 1996 Jan; 777():189-96. PubMed ID: 8624083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
    Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S
    J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGF promotes amyloid precursor protein secretion via muscarinic receptor activation.
    Haring R; Gurwitz D; Barg J; Pinkas-Kramarski R; Heldman E; Pittel Z; Danenberg HD; Wengier A; Meshulam H; Marciano D
    Biochem Biophys Res Commun; 1995 Aug; 213(1):15-23. PubMed ID: 7639729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NGF-dependent neurotrophic-like effects of AF102B, an M1 muscarinic agonist, in PC12M1 cells.
    Gurwitz D; Haring R; Pinkas-Kramarski R; Stein R; Heldman E; Karton Y; Fisher A
    Neuroreport; 1995 Feb; 6(3):485-8. PubMed ID: 7766849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.
    Fisher A; Brandeis R; Bar-Ner RH; Kliger-Spatz M; Natan N; Sonego H; Marcovitch I; Pittel Z
    J Mol Neurosci; 2002; 19(1-2):145-53. PubMed ID: 12212772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid precursor protein secretion via muscarinic receptors: reduced desensitization using the M1-selective agonist AF102B.
    Haring R; Gurwitz D; Barg J; Pinkas-Kramarski R; Heldman E; Pittel Z; Wengier A; Meshulam H; Marciano D; Karton Y
    Biochem Biophys Res Commun; 1994 Aug; 203(1):652-8. PubMed ID: 8074717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau triggers tear secretion by interacting with muscarinic acetylcholine receptors in New Zealand white rabbits.
    Martinez-Aguila A; Fonseca B; Hernandez F; Díaz-Hernandez M; Avila J; Pintor J
    J Alzheimers Dis; 2014; 40 Suppl 1():S71-7. PubMed ID: 24503615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion.
    Haring R; Fisher A; Marciano D; Pittel Z; Kloog Y; Zuckerman A; Eshhar N; Heldman E
    J Neurochem; 1998 Nov; 71(5):2094-103. PubMed ID: 9798935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local anesthetics inhibit muscarinic receptor-mediated activation of extracellular signal-regulated kinases in rat pheochromocytoma PC12 cells.
    Tan Z; Dohi S; Ohguchi K; Nakashima S; Nozawa Y
    Anesthesiology; 1999 Oct; 91(4):1014-24. PubMed ID: 10519505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists.
    Fisher A
    Jpn J Pharmacol; 2000 Oct; 84(2):101-12. PubMed ID: 11128032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line.
    Lin AL; Zhu B; Zhang W; Dang H; Zhang BX; Katz MS; Yeh CK
    Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1454-64. PubMed ID: 18385290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.
    Pavía J; de Ceballos ML; Sanchez de la Cuesta F
    Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands.
    Gurwitz D; Haring R; Heldman E; Fraser CM; Manor D; Fisher A
    Eur J Pharmacol; 1994 Mar; 267(1):21-31. PubMed ID: 8206127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment.
    Genis I; Fisher A; Michaelson DM
    J Neurochem; 1999 Jan; 72(1):206-13. PubMed ID: 9886071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M1 muscarinic receptors stimulate rapid and prolonged phases of neuronal nitric oxide synthase activity: involvement of different calcium pools.
    Wotta DR; Parsons AM; Hu J; Grande AW; El-Fakahany EE
    J Neurochem; 1998 Aug; 71(2):487-97. PubMed ID: 9681438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic activation of mitogen-activated protein kinase in PC12 cells.
    Berkeley JL; Levey AI
    J Neurochem; 2000 Aug; 75(2):487-93. PubMed ID: 10899923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists.
    Beach TG; Walker DG; Potter PE; Sue LI; Fisher A
    Brain Res; 2001 Jun; 905(1-2):220-3. PubMed ID: 11423097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels.
    Del Pino J; Zeballos G; Anadón MJ; Moyano P; Díaz MJ; García JM; Frejo MT
    Arch Toxicol; 2016 May; 90(5):1081-92. PubMed ID: 26026611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.